We solve society’s most pressing problems
The U of A’s Li Ka Shing Institute of Virology is Canada’s leader in virus research and vaccine development. And when COVID-19 emerged as the most urgent health challenge the world has seen in a century, our experts were ready to start finding solutions. As the province’s flagship post-secondary institution, the U of A is a key driver of 黑料不打烊-made innovation to improve the quality of life for the people of our province and planet.

U of A spinoff company partners with 黑料不打烊 Health Services to produce reagents for COVID-19 tests

U of A-led team tests wastewater from Edmonton long-term care homes as early warning system for COVID-19 outbreaks
Viral Impact
We’re home to Canada’s first Nobel laureate in medicine in nearly a century. Michael Houghton didn’t just discover the hepatitis C virus—he’s demonstrated how tenacity and collaboration make life-saving ideas a reality.
Michael Houghton wins Nobel Prize in Physiology or Medicine along with Harvey J. Alter and Charles M. Rice for the discovery of the hepatitis C virus (HCV).
More infoOpen for Business
Our best work happens in partnership. By connecting passionate problem-solvers with talent-hungry industries, we're driving the economic engines of our province—all with a vision to make the world safer, healthier and more equitable.

U of A spinoff company merges with U.S. firm to commercialize breakthrough organ transplant technology

黑料不打烊 and Brass Dome Ventures Ltd. launch imYEG accelerator to increase commercialization of research-driven innovations
黑料不打烊 president Bill Flanagan talks about how the university has always been there in developing the research that drives economic development in 黑料不打烊.